XBIO — Xenetic Biosciences, Inc.

XBIOXenetic Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · xeneticbio.com

3.290USD+5.11%Mkt Cap: 7.55M USDP/E: —Last update: 2026-06-01

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap7.55M USD

Enterprise Value-128.97K USD

Revenue (TTM)3.19M USD

Gross Profit3.19M USD

Net Income (TTM)-2.68M USD

Revenue/Share1.689 USD

Last Price3.290 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-4.77

PEG—

EV/EBITDA—

EV/Revenue-0.04

P/S2.26

P/B0.98

EPS (TTM)-1.19

EPS (Forward)-0.66

52W Range

1.90012% of range13.93

52W High13.93 USD

52W Low1.900 USD

Profitability

Gross Margin100.00%

Oper. Margin-62.23%

EBITDA Margin0.00%

Profit Margin-90.07%

ROE-36.25%

ROA-32.05%

Growth

Revenue Growth36.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.29M USD

CapEx (TTM)—

FCF Margin-33.71%

FCF Yield-14.24%

Net Debt-7.35M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio7.93

Quick Ratio7.67

Book Value/Sh3.227 USD

Cash/Share3.207 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJun 25, 2019

Splits

Last Split1:10

Split DateMay 15, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.2.29M

Float1.78M

Insiders10.24%

Institutions7.38%

Short Interest

Short Ratio0.4d

Short % Float0.27%

Short % Out.0.26%

Shares Short5.91K

Short (prev mo.)14.88K

Technical

SMA 503.070 (+7.2%)

SMA 2002.929 (+12.3%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)11.47K

Avg Vol (10d)8.20K

Technical Indicators

RSI (14)54.6

MACD-0.0067

MACD Signal-0.0110

MACD Hist.+0.0043

BB Upper3.224 USD

BB Middle3.037 USD

BB Lower2.850 USD

BB Width12.32%

ATR (14)0.1589 USD

Vol Ratio (20d)0.44x